2025/04/01 更新

写真a

ニシオ ヨウスケ
西尾 洋介
NISHIO Yosuke
所属
環境医学研究所 生体適応・防御研究部門 講師
職名
講師

学位 2

  1. 博士(医学) ( 2024年3月   名古屋大学 ) 

  2. 学士(医学) ( 2014年3月   名古屋大学 ) 

 

論文 14

  1. Novel <i>FBN1</i> intron variant causes isolated ectopia lentis via in-frame exon skipping Open Access

    Shimizu, N; Mashimo, Y; Yokouchi, H; Nishio, Y; Sawai, S; Ichikawa, T; Ogi, T; Baba, T; Onouchi, Y

    JOURNAL OF HUMAN GENETICS   70 巻 ( 4 ) 頁: 199 - 205   2025年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Journal of Human Genetics  

    Mutations in fibrillin-1 (FBN1) cause various clinical conditions, such as Marfan syndrome (MFS). However, the genotype–phenotype relationships underlying MFS and other conditions relevant to FBN1 mutations have not been fully elucidated. We performed whole-exome sequencing on three participants, including an affected mother–daughter pair, in a three-generation Japanese family with isolated ectopia lentis (IEL). The sequencing identified a novel single-nucleotide variant (c.1327+3A>C) in intron 11 of FBN1 that was shared between the two patients. We confirmed the co-segregation of the variant with IEL in two additional affected relatives in the family. The Combined Annotation-Dependent Depletion score of the variant was 26.1, which was indicated by SpliceAI to influence splicing, with a score of 0.93. Reverse transcription-polymerase chain reaction (RT-PCR) of mRNAs isolated from peripheral blood mononuclear cells revealed aberrant bands in all four affected individuals. Subsequent sequencing revealed that these bands originated from FBN1 transcripts lacking exon 11. The causality of the variant in the skipping of exon 11, which results in an in-frame deletion of 60 amino acids corresponding to the “hinge” region of FBN1 protein, was confirmed in a minigene experiment. Interestingly, the same result was observed for a minigene for c.1327+1G>A, a variant previously identified in two unrelated EL families without MFS manifestations. These results suggest that the c.1327+3A>C mutation in FBN1 likely leads to IEL. The findings expand our knowledge of FBN1 and provide insights into FBN1-related diseases.

    DOI: 10.1038/s10038-025-01318-0

    Open Access

    Web of Science

    Scopus

    PubMed

  2. Pathophysiological significance of the p.E31G variant in<i> RAC1</i> responsible for a neurodevelopmental disorder with microcephaly

    Nishikawa, M; Hayashi, S; Nakayama, A; Nishio, Y; Shiraki, A; Ito, H; Maruyama, K; Muramatsu, Y; Ogi, T; Mizuno, S; Nagata, K

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE   1871 巻 ( 1 ) 頁: 167520   2025年1月

     詳細を見る

    記述言語:英語   出版者・発行元:Biochimica et Biophysica Acta - Molecular Basis of Disease  

    RAC1 encodes a Rho family small GTPase that regulates actin cytoskeletal reorganization and intracellular signaling pathways. Pathogenic RAC1 variants lead to a neurodevelopmental disorder with diverse phenotypic manifestations, including abnormalities in brain size and facial dysmorphism. However, the underlying pathophysiological mechanisms have yet to be elucidated. Here, we present the case of a school-aged male who exhibited global developmental delay, intellectual disability, and acquired microcephaly. Through whole exome sequencing, we identified a novel de novo variant in RAC1, (NM_006908.5): c.92 A > G,p.(E31G). We then examined the pathophysiological significance of the p.E31G variant by focusing on brain development. Biochemical analyses revealed that the recombinant RAC1-E31G had no discernible impact on the intrinsic GDP/GTP exchange activity. However, it exhibited a slight inhibitory effect on GTP hydrolysis. Conversely, it demonstrated a typical response to both a guanine-nucleotide exchange factor and a GTPase-activating protein. In transient expression analyses using COS7 cells, RAC1-E31G exhibited minimal interaction with the downstream effector PAK1, even in its GTP-bound state. Additionally, overexpression of RAC1-E31G was observed to exert a weak inhibitory effect on the differentiation of primary cultured hippocampal neurons. Moreover, in vivo studies employing in utero electroporation revealed that acute expression of RAC1-E31G resulted in impairments in axonal elongation and dendritic arborization in the young adult stage. These findings suggest that the p.E31G variant functions as a dominant-negative version in the PAK1-mediated signaling pathway and is responsible for the clinical features observed in the patient under investigation, namely microcephaly and intellectual disability.

    DOI: 10.1016/j.bbadis.2024.167520

    Web of Science

    Scopus

    PubMed

  3. Neonatal myoclonus in Bryant-Li-Bhoj syndrome associated with a novel <i>H3F3A</i> variant Open Access

    Hojo, M; Soma, N; Yamada, K; Kobayashi, Y; Miura, M; Fujii, H; Nyuzuki, H; Nishio, Y; Oso, T; Ogi, T; Ikeuchi, T; Tohyama, J

    HUMAN GENOME VARIATION   11 巻 ( 1 ) 頁: 45   2024年12月

     詳細を見る

    記述言語:英語   出版者・発行元:Human Genome Variation  

    Bryant-Li-Bhoj syndrome (BLBS; OMIM # 619720, 619721), caused by germline H3F3A and H3F3B variants encoding histone H3.3, is characterized by mild to severe developmental delay, intellectual disability, failure to thrive, muscle tone abnormalities, and dysmorphic facial features. Here, we present a Japanese patient with a novel heterozygous p.A48G variant in H3F3A, displaying previously unrecognized symptoms of neonatal myoclonus. This case helps broaden the phenotypic spectrum of BLBS.

    DOI: 10.1038/s41439-024-00303-x

    Open Access

    Web of Science

    Scopus

    PubMed

  4. MYCN in human development and diseases Open Access

    Nishio, Y; Kato, K; Oishi, H; Takahashi, Y; Saitoh, S

    FRONTIERS IN ONCOLOGY   14 巻   頁: 1417607   2024年5月

     詳細を見る

    記述言語:英語   出版者・発行元:Frontiers in Oncology  

    Somatic mutations in MYCN have been identified across various tumors, playing pivotal roles in tumorigenesis, tumor progression, and unfavorable prognoses. Despite its established notoriety as an oncogenic driver, there is a growing interest in exploring the involvement of MYCN in human development. While MYCN variants have traditionally been associated with Feingold syndrome type 1, recent discoveries highlight gain-of-function variants, specifically p.(Thr58Met) and p.(Pro60Leu), as the cause for megalencephaly-polydactyly syndrome. The elucidation of cellular and murine analytical data from both loss-of-function (Feingold syndrome model) and gain-of-function models (megalencephaly-polydactyly syndrome model) is significantly contributing to a comprehensive understanding of the physiological role of MYCN in human development and pathogenesis. This review discusses the MYCN’s functional implications for human development by reviewing the clinical characteristics of these distinct syndromes, Feingold syndrome, and megalencephaly-polydactyly syndrome, providing valuable insights into the understanding of pathophysiological backgrounds of other syndromes associated with the MYCN pathway and the overall comprehension of MYCN’s role in human development.

    DOI: 10.3389/fonc.2024.1417607

    Open Access

    Web of Science

    Scopus

    PubMed

  5. A severe case of cardiospondylocarpofacial syndrome with a novel <i>MAP3K7</i> variant Open Access

    Nyuzuki, H; Ozawa, J; Nagasaki, K; Nishio, Y; Ogi, T; Tohyama, J; Ikeuchi, T

    HUMAN GENOME VARIATION   11 巻 ( 1 ) 頁: 8   2024年2月

     詳細を見る

    記述言語:英語   出版者・発行元:Human Genome Variation  

    Cardiospondylocarpofacial syndrome (CSCFS) is a congenital malformation characterized by growth retardation, facial features, short toes with carpal and tarsal fusion, extensive posterior neck vertebral fusion, congenital heart disease, and deafness. Here, we report a severe case of CSCFS with a novel variant, p.Thr187Ile, in MAP3K7. Thr187 is the main phosphorylation site for TGF-beta-activated kinase 1 encoded by MAP3K7, and this variant may cause significant abnormalities in downstream signaling.

    DOI: 10.1038/s41439-024-00265-0

    Open Access

    Web of Science

    Scopus

    PubMed

▼全件表示